Patients undergoing certain major surgeries may have a shorter recovery period if they have a history of cannabis use.
According to a new study published journal last month joint arthroplastyThe study focused on patients undergoing total joint arthroplasty (TJA), or hip or knee replacement surgery.
According to the authors of this study, patients with a history of ‘cannabis use disorder’ or ‘CUD’ had a ‘significantly shorter length of hospital stay (LOS) and a higher home discharge rate after primary TJA compared to controls. rice field”.
As the authors noted, changes in U.S. laws and attitudes toward cannabis use have forced the medical community to consider how to manage patient care. “The increasing legalization and decriminalization of cannabis across the United States is associated with a significant increase in self-reported cannabis use among surgical patients, including those undergoing total joint replacement surgery. there are,” they wrote. “Cannabinoids are used primarily for recreational purposes,” but “cannabinoid metabolites have shown analgesic and anti-inflammatory properties and have been proposed as an alternative to opioids in the management of acute and chronic pain.”
“Although cannabis use can possibly be beneficial in the postoperative setting, cannabis use disorder (CUD) is defined in part as a pattern of problematic cannabis use leading to clinically significant disability or distress. and correlated with increased postoperative pain and opioid use in orthopedic surgery.”
“With the gradual legalization of cannabis use, it becomes increasingly important for clinicians to understand the characteristics of this evolving patient population. By understanding the characteristics, postoperative clinical and economic outcomes, orthopedic surgeons and multidisciplinary medical teams can better coordinate the care and management of these patients.
Taken together, the authors suggest, this suggests that subsequent research will “more closely assess the demographic profile of patients with both recreational use and substance use disorders, along with potential barriers in access to health care.” should aim at.”
“This understanding should be linked to the expansion and improvement of public health initiatives and the development of frameworks to better deliver substance use screening and interventions to this patient population. Combined with the development of a well-designed perioperative protocol, it has the potential to optimize postoperative and overall health outcomes in this at-risk patient population,” the authors wrote.
However, the authors offered some caveats, noting that “this study is limited for several reasons.”
For example, it noted that patients with cannabis use disorder “are encouraged to leave the hospital as soon as possible and return home to continue using cannabis and other substances.”
“Because such use may be associated with problematic behavioral changes and abandonment of social, occupational, or recreational activities, these patients should be , may be at risk of worsening postoperative and overall health outcomes. orthopedic surgeons and multidisciplinary medical and social services teams should continue to be aware of the risks these patients face and the long-term Perioperative interventions should be considered to optimize both outcomes and general health improvement,” they wrote.
As NORML pointed out, Other “studies, including recently published papers, have reported opposite results. lancet determined that the patient has diagnosed [with] Cannabis use disorders were more likely to require advanced post-procedure health care than those with no recent history of use.”